Executive Decision Making for Pharma & Biotech 2024

Portfolio prioritization, decision analysis, agile capacity management, resource forecasting, risk mitigation, and overall strategic decision making are becoming increasingly difficult in today’s ever-changing pharma R&D landscape. Cambridge Healthtech Institute’s Biopharma Strategy Series presents Executive Decision Making for Pharma and Biotech 2024, 3 days of high-level content, interactive discussions and networking, breakout roundtables, 1:1 meetings, and much more! Attendees will leave with new tools and organizational strategies to optimize portfolio insights and decision making; and align resource planning, allocation, and capacity management with portfolio prioritization.